Characterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy Index
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Costanza Paoletti, M.D.
University of Michigan Rogel Cancer Center
Principal Investigator - Daniel F Hayes, M.D.
University of Michigan Rogel Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mt. Sinai Hosp., Marvette Koffler Breast Center
Toronto, Ontario, Canada
- Princess Margaret Hospital
Toronto, Ontario, Canada
- Arizona Oncology Associates
Phoenix, Arizona, United States
- Florida Cancer Specialists
Fort Myers, Florida, United States
- Florida Cancer Specialists
St. Petersburg, Florida, United States
- Dana-Faber Cancer Institute
Boston, Massachusetts, United States
- University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
- Minnesota Oncology Hematology
Minneapolis, Minnesota, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Nebraska Cancer Specialists
Omaha, Nebraska, United States
- Comprehensive Cancer Centers of Nevada
Henderson, Nevada, United States
- New York Oncology Hematology
New York, New York, United States
- Waverly Hematology Oncology
Cary, North Carolina, United States
- Duke University
Durham, North Carolina, United States
- Northwest Cancer Specialists
Portland, Oregon, United States
- Abramson Cancer Center, University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Thomas Jefferson University
Philadelphia, Pennsylvania, United States
- Tennessee Oncology, Pllc
Nashville, Tennessee, United States
- Texas Oncology - Baylor
Dallas, Texas, United States
- Texas Oncology
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Apr 2013
- Primary completion
- 10 Nov 2016
- Completion
- 10 Nov 2016
- Last update posted
- 8 Mar 2017
- Registered enrollment
- 121
- Registry id
- NCT01701050
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.